Difference between revisions of "Event:298"
Line 49: | Line 49: | ||
!Molecular Initiating Event? | !Molecular Initiating Event? | ||
!Essentiality | !Essentiality | ||
+ | |||
+ | |- | ||
+ | |||
+ | |[[VEGF Inhibition Leading to Vascular Disruption During Embryonic Development]]||No|| | ||
|- | |- |
Revision as of 21:32, 27 May 2014
<html> <style> .ui-autocomplete {
max-height: 100px; overflow-y: auto; overflow-x: hidden; padding-right: 20px;
}
- html .ui-autocomplete {
height: 100px;
}
.ui-menu .ui-menu-item a
{ display: block; padding: 1px 1px 1px 1px; text-decoration: none; cursor: pointer; font-size: 13px; }
</style>
<link type='text/css' rel='stylesheet' href='/aopwiki/extensions/jquery-ui-1.9.2/themes/base/jquery-ui.css'> <script type="text/javascript" src="/aopwiki/extensions/jquery-ui-1.9.2/ui/jquery-ui.js"></script> <script type="text/javascript" src="/aopwiki/extensions/EPA/Common_Functions.js"></script> <script type="text/javascript" src="/aopwiki/extensions/EPA/MOA_Species.js"></script> <script type="text/javascript" src="/aopwiki/extensions/EPA/MOA_Chemicals.js"></script> <script type="text/javascript" src="/aopwiki/extensions/EPA/MOA_Key_Event.js"></script> </html>
Contents
Key Event Overview
AOPs Including This Key Event
AOP Name | Molecular Initiating Event? | Essentiality |
---|---|---|
VEGF Inhibition Leading to Vascular Disruption During Embryonic Development | No |
Taxonomic Applicability
<html> <button id="SpeciesList">Add Species from list</button> </html>
Common Name | Scientific Name | Evidence | Links |
---|
Previously Approved or Guideline Methods
Level of Biological Organization
How this Key Event works
How it is Measured or Detected
Methods that have been previously reviewed and approved by a recognized authority should be included in the Overview section above. All other methods, including those well established in the published literature, should be described here. Consider the following criteria when describing each method: 1. Is the assay fit for purpose? 2. Is the assay directly or indirectly (i.e. a surrogate) related to a key event relevant to the final adverse effect in question? 3. Is the assay repeatable? 4. Is the assay reproducible?